ALS is primarily characterized by progressive upper and lower motor neuron degeneration, resulting in muscle weakness, wasting, spasticity, fasciculations, bulbar dysfunction, and respiratory failure.1-3

Key clinical indicators of ALS include:

  • A combination of upper and lower motor neuron symptoms1,2
  • The preservation of brisk limb reflexes despite severe muscle atrophy1
  • Dysarthria (of spastic or flaccid presentation)1,2
  • Note: sensory and autonomic involvement is uncommon and typically occurs later in the disease course1,2

Patients may also experience symptoms related to extrapyramidal, cerebellar, sensory, autonomic, urinary, or oculomotor involvement, with cognitive impairment the most common nonmotor presentation.1

file_download Download in HQ

Related content

image Image Clinical spectrum of MND-FTD
The MND-FTD clinical spectrum

Motor neuron disease (MND) and frontotemporal dementia (FTD) were once seen as separate conditions, one affecting movement and the other cognition and behaviour. Growing evidence now places them on the same disease spectrum, linked by shared clinical features, genetic causes, and underlying pathology.

17.11.2026 ALS-FTD
grid_view Slide Deck
ALS-FTD spectrum – History, Definitions and Diagnosis
17.11.2026 ALS-FTD
image Image Microscopy images showing skein-like and compact protein inclusions in the cytoplasm of degenerating motor neurons.
Protein inclusions in the cytoplasm of degenerating motor neurons

Motor neuron degeneration in ALS is associated with abnormal protein aggregation, including characteristic skein-like and compact cytoplasmic inclusions.

17.11.2026 ALS-FTD